Lincomycin - PharmaKB

Lincomycin

Lincocin, Lincomycin (lincomycin) is a small molecule pharmaceutical. Lincomycin was first approved as Lincocin on 1982-01-01. It is used to treat pneumococcal infections and staphylococcal infections in the USA.

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

Therapeutic Areas

Therapeutic Area	MeSH
infections	D007239

Trade Name

FDA

EMA

Lincocin (generic drugs available since 2015-06-04)

Drug Products

FDA

EMA

New Drug Application (NDA)

Abbreviated New Drug Application (ANDA)

Lincomycin hydrochloride

Tradename	Company	Number	Date	Products
LINCOCIN	Mylan	N-050317 RX	1982-01-01	1 products, RLD, RS

Show 1 discontinued

Labels

FDA

EMA

No data

Indications

FDA

EMA

Indication	Ontology	MeSH	ICD-10
pneumococcal infections	EFO_0000772	D011008	J13
staphylococcal infections	—	D013203	A49.01

Agency Specific

FDA

EMA

No data

Patent Expiration

No data

ATC Codes

J: Antiinfectives for systemic use

— J01: Antibacterials for systemic use

— J01F: Macrolides, lincosamides and streptogramins

— J01FF: Lincosamides

— J01FF02: Lincomycin

HCPCS

Code	Description
J2010	Injection, lincomycin hcl, up to 300 mg

Clinical

Clinical Trials

4 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Bacteremia	D016470	EFO_0003033	R78.81	—	—	—	1	—	1

Indications Phases 3

No data

Indications Phases 2

No data

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Osteomyelitis	D010019	EFO_0003102	M86	1	—	—	—	—	1
Bacterial infections	D001424	—	A49	1	—	—	—	—	1

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Aortic valve stenosis	D001024	HP_0001650	—	—	—	—	—	1	1

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	Lincomycin
INN	lincomycin
Description	Lincomycin is a carbohydrate-containing antibiotic produced by the actinomyces Streptomyces lincolnensis. It has a role as an antimicrobial agent and a bacterial metabolite. It is a carbohydrate-containing antibiotic, a S-glycosyl compound, a monocarboxylic acid amide, a pyrrolidinecarboxamide and a L-proline derivative.
Classification	Small molecule
Drug class	antibiotics (Streptomyces strain)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1